PKC-theta inhibitors (CompleGen)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePKC-theta inhibitors (CompleGen)
Drug Alias Nameprotein kinase C-theta inhibitors (CompleGen)CGX-1079CGX-0471
ClassificationSmall molecules
Mechanisms of ActionProtein kinase C theta inhibitorsAnticancer protein kinase inhibitorsImmunosuppressants +[4] 
TargetsProtein kinase C theta
Therapy Area/IndicationsInflammationAutoimmune DiseasesLymphoma, T-Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCompleGen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCompleGen Inc
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesLymphoma, T-Cell +[4] 

Other Information

ATC CodeN/A
Related LinksN/A